BCL2L1 and breast carcinoma: Fourth, nuclear Bcl-xL, but not mitochondrial Bcl-xL and cytosolic Bcl-xL, promoted EMT and migration of panNET and breast cancer cells, although nuclear Bcl-xL failed to protect cells from apoptosis (Fig. 8c–h).